Pharmacokinetics of troglitazone in healthy subjects and in patients with type II diabetes mellitus

被引:0
|
作者
Loi, CM
Vassos, AB
Randinitis, EJ
Koup, JR
Sedman, A
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,DEPT PHARMACOKINET DRUG METAB,ANN ARBOR,MI
[2] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,DEPT CLIN PHARMACOL,ANN ARBOR,MI
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:PI87 / PI87
页数:1
相关论文
共 50 条
  • [1] Troglitazone in type II diabetes mellitus
    Sparano, N
    Seaton, TL
    PHARMACOTHERAPY, 1998, 18 (03): : 539 - 548
  • [2] Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
    Schwartz, S
    Raskin, P
    Fonseca, V
    Graveline, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13): : 861 - 866
  • [3] Effects of troglitazone on coagulation-fibrinolysis abnormalities in patients with type II diabetes mellitus
    Kubo, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (08): : 537 - 544
  • [4] The effect of troglitazone on insulin sensitivity in normal subjects and type 2 diabetes mellitus patients.
    Yu, JG
    Kruszynska, YT
    Frias, JP
    Armstrong, D
    Olefsky, JM
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 77A - 77A
  • [5] Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus
    Sambol, NC
    Chiang, J
    OConner, M
    Liu, CY
    Lin, ET
    Goodman, AM
    Benet, LZ
    Karam, JH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (11): : 1012 - 1021
  • [6] Effects of troglitazone in Hispanic patients with type 2 diabetes mellitus
    Mavandadi, A
    Gong, WC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (09): : 494 - 501
  • [7] Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
    Duong, Janna K.
    Kumar, Shaun S.
    Kirkpatrick, Carl M.
    Greenup, Louise C.
    Arora, Manit
    Lee, Toong C.
    Timmins, Peter
    Graham, Garry G.
    Furlong, Timothy J.
    Greenfield, Jerry R.
    Williams, Kenneth M.
    Day, Richard O.
    CLINICAL PHARMACOKINETICS, 2013, 52 (05) : 373 - 384
  • [8] Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
    Janna K. Duong
    Shaun S. Kumar
    Carl M. Kirkpatrick
    Louise C. Greenup
    Manit Arora
    Toong C. Lee
    Peter Timmins
    Garry G. Graham
    Timothy J. Furlong
    Jerry R. Greenfield
    Kenneth M. Williams
    Richard O. Day
    Clinical Pharmacokinetics, 2013, 52 : 373 - 384
  • [9] Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
    Inzucchi, SE
    Maggs, DG
    Spollett, GR
    Page, SL
    Rife, FS
    Walton, V
    Shulman, GI
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13): : 867 - 872
  • [10] DETECTION OF MICROALBUMINURIA BY RADIOIMMUNOASSAY IN PATIENTS WITH DIABETES-MELLITUS TYPE-I AND TYPE-II AND IN HEALTHY-SUBJECTS
    ROHAC, M
    HOWORKA, K
    ENDLER, AT
    GABL, F
    BRATUSCHMARREIN, P
    WALDHAUSL, W
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1986, 24 (10): : 771 - 771